Literature DB >> 7043268

Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.

W H Frishman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043268     DOI: 10.1056/NEJM198206173062404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Authors:  William H Frishman; Mamata Alwarshetty
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.

Authors:  W H Frishman; E J Lazar; G Gorodokin
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption.

Authors:  K Balon; B U Riebesehl; B W Müller
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 5.  The new beta-adrenergic antagonists.

Authors:  D C Chung; M J Laschuk
Journal:  Can Anaesth Soc J       Date:  1984-07

6.  Skin irritation induced by topically applied timolol.

Authors:  K Kubota; E Koyama; K Yasuda
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 7.  Cardiovascular therapies in the 1990s. An overview.

Authors:  R C Becker; J M Gore
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

8.  Effect of timolol on clinical features and echocardiographic assessment of left ventricular function in hyperthyroidism.

Authors:  B E Griffiths; F M Creagh; J H Lazarus; R John; S Kadury
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 9.  Clinical use of beta-adrenoceptor blockade in systemic hypertension.

Authors:  J Nadelmann; W H Frishman
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

10.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.